EU-STRA-Strålevern

The aim of the DoReMi is to promote sustainable integration of low dose risk research in Europe in order to more effectively resolve the key policy questions identified by the High Level Expert Group on Low Dose Risk Research (www.hleg.de), namely the sha pe/s of dose response relationship/s, variation in risk between individuals, tissue sensitivity for cancer, radiation quality, risks from internal exposures and non-cancer effects. The DoReMi provides an operational tool for the further development of the MELODI platform (Multidisciplinary European Low Dose Risk Research Initiative) consisting of major national bodies and research programmes that have long term commitment in low dose risk research in Europe.The Joint Programme of Activities of the DoReMi includes: (i) a Joint Programme of Research; (ii) a Joint Programme of Integration to realise a successful strategy for sustainable integration of the key players in Europe; and (iii) a Joint Programme for the Spreading of Excellence, covering in particul ar knowledge management, training & mobility and its implementation. The project has a multi-disciplinary approach including interfaces with the broader (i.e. non-radiation) biological, toxicological and epidemiological communities. The DoReMi is expected to lead to sustainable integration of low dose risk research in Europe which, in the longer term, would lead to an effective approach to resolution of the key remaining policy questions in radiation protection. The Norwegian part of the project will focu s on using the UMB irradiation facility. The facility will be upgraded, calibrated and prepared for in vivo irradiation experiments of animals according to the needs of other DoReMi partners. The objective is to open the facility to DoReMi participants fo r beam time of 4-6 weeks per year (total 20 weeks over a 4 year period) as part of WP4: Infrastructures. Norewgian partners will also take part in WP2: Structuring of MELODI.